847-797-8000. " /> Defective Prescription Drugs

121 S. Wilke Road, Suite 301, Arlington Heights, IL 60005

Home and Hospital Visits for Your Convenience

Call for a FREE Consultation

847-797-8000

What are the Claims Against Prilosec and Nexium?

Nexium and Prilosec are two drugs produced by pharmaceutical manufacturer AstraZeneca that are used to treat gastroesophageal reflux disease (GERD). They belong to a category of drugs known as proton pump inhibitors (PPIs) and both are available to users without a prescription.

Another similarity between the drugs is that both have been named in defective drug lawsuits alleging that they are unreasonably dangerous and that their manufacturer was negligent by failing to properly test the drugs, failing to warn consumers about the risks associated with taking these drugs, and that it actively concealed the drugs' dangers to the Food and Drug Administration (FDA) and misrepresented the drugs in its marketing materials.

...

Understanding the 2017 Invokana Dangerous Drug Claims

Numerous claims have been filed against Johnson & Johnson and Janssen Pharmaceuticals, the manufacturers of diabetes medication Invokana. These claims allege that the manufacturers did not adequately warn doctors and their patients of the drug's potential side effects, which include an increased risk of kidney failure, foot and leg amputations, and ketoacidosis.

Like manufacturers of other consumer products, drug manufacturers have the responsibility to ensure that their products are safe for consumers to use before releasing them to the market. When a product cannot be released without some potential for side effects, manufacturers must clearly warn patients and the physicians who prescribe their products about these side effects so they can make informed decisions about using the drugs. A patient who is harmed because of a manufacturer's failure to disclose a drug's side effects can seek compensation for his or her related damages through a defective drug claim.

...

How Can Abilify Hurt Me?

Abilify is an antipsychotic drug used to treat bipolar disorder, depression, schizophrenia, and Tourette Syndrome. In certain cases, it can also help autistic individuals manage their irritability. Its generic name is Aripiprazole. It is also sold under the brand names Aristrada and Abilify Maintena.

Any drug can have potentially harmful side effects. Drug manufacturers have the responsibility to disclose these side effects to doctors who might prescribe the drug and patients who might take it. When a patient suffers from these side effects without realizing the risk he or she took by taking the medication, the patient may seek compensation for his or her resulting damage through a defective drug claim.

...

A state inspection of a pharmacy in Fayetteville, North Carolina, has led to the recall of more than 600 drugs in a variety of dosages and formulations, officials announced in late March. The U.S. Food and Drug Administration (FDA) and the North Carolina Board of Pharmacy (NCBOP) have issued a warning to medical professionals and patients regarding all compounded drugs made or distributed by the Prescription Center pharmacy, which has been since shut down.

Compounded Drug Recall

The NCBOP said in a news release that it was recalling all nonsterile and sterile products that were compounded, repackaged, and distributed by the pharmacy from September 10, 2014 to March 10, 2015. The listing of recalled products includes antidepressants, antibiotics, antiviral medications, immunosupressants, and others which were distributed to all 50 states and Canada. “This recall is due [to] the pharmacy's inability to ensure sterility, stability, and potency for these products,” the Board of Pharmacy said. While no complaints of injuries have been received by the board, the NCBOP and FDA are advising clinicians to quarantine any products from the Prescription Center and not to administer them to human or animal patients.

...
Tagged in: Drugs Fda Recall

Though the manufacturer has come under fire for defective devices in the past, this year the da Vinci Sp Intuitive single port robot system used in surgical procedures is expected to hit the consumer market, according to MedGadget.com. The system is designed to allow for single-incision surgeries, and is a competitor to manufacturing giant Titan. The system was first introduced as a prototype more than five years ago, but only received approval from the U.S. Food and Drug Administration (FDA) last year.

The first da Vinci Intuitive surgical robot was introduced more than a decade ago. When the company first went public, 15 years ago, it posted $10 million in annual sales, though the robot had only been used on 600 patients worldwide. The machine was thought by the medical professional community to be a great symbol of technological surgical advance, and, according to ModernHealthcare.com, “one of the most coveted status symbols of 21st-century medicine.” Yet the $2.3 million machine caused serious side effects and even injury in several patients, due to a disregard for patient safety on the part of the manufacturer and aggressive marketing tactics that often preceded patient testing.

As of 2013, according to ModernHealthcare.com, da Vinci was facing 25 product liability lawsuits. Many of the lawsuits allege that the manufacturer failed to properly train surgeons on how to use the innovative machine, and instead pushed through patents and marketing efforts before hospitals were equipped enough to handle the new technology.

...
Elite Lawyer Badge Illinois State Bar Association Illinois Trial Lawyers Asscociation NACBA Manta Member BBB North western suburban bar association
Back to Top